Japan's Diabetes Market will reach US $3.39 Billion in 2028, and it will expand at a CAGR of 2.75% from 2023 to 2028, according to the publisher. Diabetes is a non-communicable disease caused by high blood glucose levels and is currently one of Japan's most important public health problems. Japan has around 11 million people with diabetes, according to IDF 2021. Aging and obesity contribute to the increase in diabetes prevalence. Of this, the rapidly aging population is a significant concern, which makes disease management a challenge. Apart from disease management, the economic impact of diabetes in Japan is substantial.Japan Diabetes Market was US$ 2.88 Billion in 2022
Ageing Population will Foster the Growth of Japan's Diabetes Market
Japan has the highest proportion of the aging population globally; almost a quarter of the population is 65 plus. The increase in the geriatric population is an enormous burden for the Japanese government because the prevalence of the aging disease is rising rapidly. So the Japanese government has prioritized dealing with an aging population, and it is expected that government will allocate a skyrocketed healthcare budget in 2025 for aging. Therefore rising prevalence and increased public expenditure will boost Japan's diabetes Market. Japan, Diabetes Market was US$ 2.88 Billion in 2022.Type 2 Diabetes is Increasing Year on Year
Japan has a low incidence of type 1 diabetes because the Japanese are genetically homogeneous. However, Japan has one of the largest elderly populations in the world, which is more susceptible to the onset of type 2 diabetes. In addition, there are many contributing factors to diabetes development in Japanese people, including dietary patterns, physical inactivity, smoking, and many others. Therefore, Japan's diabetes care devices are one of the high-potential markets for development.SMBG Devices is one of the most Prominent Markets
Japan's Diabetes industry has been divided into SMBG, CGM, and Insulin Pumps. SMBG holds a substantial revenue share owing to the high diabetes incidence rate. In addition, changing lifestyles, unhealthy dietary habits, physical inactivity, and excessive body weight are prominent factors contributing to the disease burden. Thus, the need to monitor blood glucose level for the optimization of treatment regime among these patients drive the japan market revenue. Moreover, a higher prevalence rate across developed countries with awareness regarding SMBG among the type 2 diabetes population will fuel the market revenue.Japan Government Initiative
Even with such colossal healthcare and drug expenditure on the treatment of diabetes, the number of patients undergoing dialysis due to diabetes continues to increase, and the number of chronic dialysis patients in Japan per capita is by far the largest in an international comparison. To reduce ever-increasing social security expenditure, the Government of Japan is attempting to improve the efficiency of healthcare services. The premise of these efforts is that there exists a high degree of waste in the present system. However, the problem lies in the over-provision of health care and extends to under-provision. In recent years, Japan's disease structure has been changing due to the rapid aging of the population and lifestyle changes.As a result, there are ever-increasing deaths and disabilities associated with non-communicable diseases (NCDs), such as cancer, cardiovascular diseases, and diabetes. Moreover, these NCDs have accounted for more than 30% of national healthcare expenditures. Therefore, in 2000, the Japanese government launched the National Health Promotion Movement in the 21st Century, known as Health Japan 21.
Key Company
The major players are Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care.In June 2022, Sanofi and Health2Sync announced that they would work together on new features such as connected caps for insulin products that can automatically record delivered doses, rather than requiring them to be logged manually, and titration alerts from the app to indicate when a change in insulin dose may be required.
In March 2022, Quantum Operation Inc., a Tokyo-based healthcare IoT startup, presented the world's first non-invasive glucose monitor capable of continuous measurement. It measures the blood sugar from the wrist without any pricks.
This report titled “Japan Diabetes Market & Forecast, By Self-Monitoring Blood Glucose (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Insulin Pump (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies) Company (Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)” provides a complete analysis of Japan Diabetes Market.
Segments Market based on Devices
1. Continuous Glucose Monitoring (CGM)2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pump
Japan Diabetes Sub-Segment Analysis
Self-Monitoring Blood Glucose Device (SMBG)
1. Test Strips Market2. Lancet Market
3. Meter Market
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement
2. Continuous Glucose Monitoring (CGM)
1. Glucose Sensor Market2. CGM Transmitter Market
3. CGM User
4. CGM Reimbursement
Insulin Pump Market
1. Insulin Pump Market2. Insulin Pump Users
3. Reimbursement Policies
All the 7 Companies Studied in the Report have been Studied from 3 Points
- Company Overview
- Recent Developments
- Financial Insight
Company Analysis
1. Medtronic2. Insulet Corporation
3. Abbott Laboratories
4. DarioHealth Crop
5. Dexcom, Inc
6. Roche Diagnostic
7. Tandem Diabetes Care
Table of Contents
1. Introduction2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Japan Diabetes Market
6. Japan Diabetes Population
6.1 Type 1 Diabetes
6.2 Type 2 Diabetes
7. Share Analysis - Japan Diabetes Market
7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) - Japan Market & Users
8.1 Japan - CGM Market by Components
8.1.1 Glucose Sensor Market
8.1.2 CGM Transmitter Market
8.2 CGM User
8.3 Reimbursement Policies of CGM Devices in Japan
9. Blood Glucose Device (SMBG) -Japan Market & Users
9.1 Market
9.1.1 Type 1 Diabetes Market
9.1.2 Type 2 Diabetes Market
9.2 Test Strips Market
9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes
9.3 Lancet Market
9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes
9.4 Meter Market and Forecast
9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes
9.5 Blood Glucose (SMBG) Users
9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes
9.6 Reimbursement Policies of Blood Glucose Devices in Japan
10. Insulin Pump - Japan Market & Users
10.1 Insulin Pump Market
10.1.1 Type 1 Diabetes Market
10.1.2 Type 2 Diabetes Market
10.2 Insulin Pump User
10.2.1 Type 1 Insulin Pump User
10.2.2 Type 2 Insulin Pump User
10.3 Differentiation Points of Insulin Pump Products in Japan
10.3.1 Animas Vibe
10.3.2 Medtronic 530G with Enlite
10.3.3 InsuletOmniPod
10.3.4 Tandem t: slim
10.3.5 Roche Accu-Chek Combo
10.4 Training Model for Patients & HCP - of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
10.4.1 Medtronic
10.4.1.1 Training Guidelines for Insulin Pump Therapy to New Patients
10.4.1.2 Training Model for HCP (HealthCare Professional)
10.5 Insulet Corporation
10.5.1 Training Structure for New Patients - Insulet Corporation
10.6 Animas Corporation
10.6.1 Training Modules for New Patients
10.6.2 Training Modules for HCP (Health Care Professional)
10.7 Tandem Diabetes Care
10.8 Reimbursement Policies Insulin Pump
11. Insulin Pump - Company Analysis
11.1 Medtronic
11.1.1 Overview
11.1.2 Recent Development
11.1.3 Revenue
11.2 Insulet Corporation
11.2.1 Overview
11.2.2 Recent Development
11.2.3 Revenue
12. SMBG - Company Analysis
12.1 Abbott Laboratories
12.1.1 Business Overview
12.1.2 Recent Development
12.1.3 Revenue
12.2 DarioHealth Corp
12.2.1 Business Overview
12.2.2 Recent Development
12.2.3 Revenue
13. CGM - Company Analysis
13.1 DexcomInc
13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue
13.2 Roche
13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue
13.3 Tandem Diabetes Care
13.3.1 Overview
13.3.2 Recent Development
13.3.3 Revenue
List of Figures:
Figure 01: Japan - Diabetes Market (Billion US$), 2017 - 2022
Figure 02: Japan - Forecast for Diabetes Market (Billion US$), 2023 - 2028
Figure 03: Japan - Type 1 Diabetes Population (Thousand), 2017 - 2022
Figure 04: Japan - Forecast for Type 1 Diabetes Population (Thousand), 2023 - 2028
Figure 05: Japan - Type 2 Diabetes Population (Thousand), 2017 - 2022
Figure 06: Japan - Forecast for Type 2 Diabetes Population (Thousand), 2023 - 2028
Figure 07: Japan - Glucose Sensor Market (Million US$), 2017 - 2023
Figure 08: Japan - Forecast for Glucose Sensor Market (Million US$), 2023 - 2028
Figure 09: Japan - CGM Transmitter Market (Million US$), 2017 - 2023
Figure 10: Japan - Forecast for CGM Transmitter Market (Million US$), 2023 - 2028
Figure 11: Japan - CGM User (Thousand), 2017 - 2023
Figure 12: Japan - Forecast for CGM User (Thousand),2023 - 2028
Figure 13: Japan - Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 14: Japan - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 15: Japan - Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 16: Japan - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 17: Japan - Test Strips Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 18: Japan - Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 19: Japan - Test Strips Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 20: Japan - Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 21: Japan - Lancet Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 22: Japan - Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 23: Japan - Lancet Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 24: Japan - Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 25: Japan - Meter Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 26: Japan - Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 27: Japan - Meter Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 28: Japan - Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 29: Japan - Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 - 2022
Figure 30: Japan - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 - 2028
Figure 31: Japan - Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 - 2022
Figure 32: Japan - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 - 2028
Figure 33: Japan - Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 34: Japan - Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 35: Japan - Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 36: Japan - Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 37: Japan - Insulin Pump Type 1 Users (Thousand), 2017 - 2022
Figure 38: Japan - Forecast for Insulin Pump Type 1 Users (Thousand), 2023 - 2028
Figure 39: Japan - Insulin Pump Type 2 Users (Thousand), 2017 - 2022
Figure 40: Japan - Forecast for Insulin Pump Type 2 Users (Thousand), 2023 - 2028
Figure 41: Medtronic - Global Revenue (Billion US$), 2017 - 2022
Figure 42: Medtronic - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 43: Insulet Corporation - Global Revenue (Million US$), 2017 - 2022
Figure 44: Insulet Corporation - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 45: Abbott Laboratories - Global Revenue (Billion US$), 2017 - 2022
Figure 46: Abbott Laboratories - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 47: DarioHealth Corp - Global Revenue (Million US$), 2017 - 2022
Figure 48: DarioHealth Corp - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 49: Dexcom Inc - Global Revenue (Million US$), 2017 - 2022
Figure 50: Dexcom Inc - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 51: Roche - Global Revenue (Billion US$), 2017 - 2022
Figure 52: Roche - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 53: Tandem Diabetes Care - Global Revenue (Million US$), 2017 - 2022
Figure 54: Tandem Diabetes Care - Forecast for Global Revenue (Million US$), 2023 - 2028
List of Tables:
Table 01: Japan - Diabetes Market Share by Type (Percent), 2017 - 2022
Table 02: Japan - Forecast for Diabetes Market Share by Type (Percent), 2023 - 2028
Companies Mentioned
- Medtronic
- Insulet Corporation
- Abbott Laboratories
- DarioHealth Crop
- Dexcom, Inc
- Roche Diagnostic
- Tandem Diabetes Care
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | March 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 2.88 Billion |
| Forecasted Market Value ( USD | $ 3.39 Billion |
| Compound Annual Growth Rate | 2.7% |
| Regions Covered | Japan |
| No. of Companies Mentioned | 7 |
